ACCORD HLTHCARE Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACCORD HLTHCARE, and what generic and branded alternatives to ACCORD HLTHCARE drugs are available?
ACCORD HLTHCARE has one hundred and fifty-four approved drugs.
There are three tentative approvals on ACCORD HLTHCARE drugs.
Summary for ACCORD HLTHCARE
| US Patents: | 0 |
| Tradenames: | 131 |
| Ingredients: | 128 |
| NDAs: | 154 |
Drugs and US Patents for ACCORD HLTHCARE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accord Hlthcare | AMLODIPINE BESYLATE | amlodipine besylate | TABLET;ORAL | 202553-001 | Apr 29, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Accord Hlthcare | ATROPINE SULFATE | atropine sulfate | SOLUTION;INTRAVENOUS | 212868-001 | Jul 26, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Accord Hlthcare | DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE | amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | TABLET;ORAL | 214347-007 | Nov 22, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ACCORD HLTHCARE drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
| ➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
